Gufic Biosciences Limited(IN:GUFICBIO)
₹432.50+8.40 (+1.98%)
IN:GUFICBIO
Gufic Biosciences Limited Revenue
₹432.50
At close:+8.40 (+1.98%)
Want to see IN:GUFICBIO full AI Analyst Report?
Gufic Biosciences Limited (GUFICBIO) Revenue
0 Followers
Gufic Biosciences Limited Revenue
Gufic Biosciences Limited had a revenue of 2.61B in the quarter ending Jun 30, 2026, with 3.57%. This bring the company's revenue in the last twelve months to 9.81B, Increased 3.93%. In the fiscal year ending Mar 31, 2026, Gufic Biosciences Limited had annual revenue of 9.44B with 15.15% growth.
- Revenue (ttm)
- 9.81B
- Revenue Growth
- 18.17%
- P/S Ratio
- 4.59
- Revenue/Employee
- INR 6,331,366
- Employees
- 1,491
- Market Cap
- INR 43.37B
Revenue Chart
Gufic Biosciences Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.44B | 1.24B | 15.15% |
| Mar 31, 2025 | 8.20B | 131.40M | 1.63% |
| Mar 31, 2024 | 8.07B | 1.16B | 16.80% |
| Mar 31, 2023 | 6.91B | -885.35M | -11.36% |
| Mar 31, 2022 | 7.79B | 2.91B | 59.76% |
| Mar 31, 2021 | 4.88B | 1.09B | 28.74% |
| Mar 31, 2020 | 3.79B | 280.68M | 8.00% |
| Mar 31, 2019 | 3.51B | 498.05M | 16.55% |
| Mar 31, 2018 | 3.01B | 608.62M | 25.35% |
| Mar 31, 2017 | 2.40B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:GUFICBIO | 9.81B |
| IN:BLISSGVS | 10.74B |
| IN:INDOCO | 18.94B |
| IN:MOREPENLAB | 22.86B |
| IN:ORCHPHARMA | 9.43B |
| IN:UNICHEMLAB | 23.69B |

